07 April 2026
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
AMERICAN VANGUARD CORP
CIK: 5981•3 Annual Reports•Latest: 2026-03-16
10-K / March 16, 2026
Revenue:$515,114,000
Income:-$49,882,000
10-K / June 2, 2025
Revenue:$547,306,000
Income:-$126,340,000
10-K / March 28, 2024
Revenue:$579,371,000
Income:$7,519,000
10-K / March 16, 2026
American Vanguard Corporation
Entity and scope
- The company is American Vanguard Corporation and its consolidated subsidiaries (referred to as “AVD”).
- The excerpt includes forward-looking statements and references the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, reflecting disclosure of risks and uncertainties affecting the company’s operations and financial results.
Primary business activities and focus
- Manufacture and sale of products related to pesticides and PFAS (per- and polyfluoroalkyl substances) as referenced in the filing.
- Product development and commercialization, with implications for capacity and supply utilization and dependence on third-party suppliers.
- Global operations and supply chains, including exposure to foreign exchange, foreign investments, and tariff impacts.
- Regulatory and environmental compliance, including interactions with the U.S. Environmental Protection Agency, registration reviews, and related petitions or findings.
- Financial and corporate management activities such as managing debt, borrowing under a credit facility, customer prepayments, asset impairments, and internal control remediation.
- Cybersecurity and information security measures and risks.
- Exposure to macroeconomic and weather-related factors that can affect operations and demand.
- Strategic growth initiatives, including acquisitions and business improvement programs, dependent on available capital and cost considerations.
Risk factors highlighted
- Changes in environmental and governmental regulations, including EPA actions and registration reviews.
- Product liability and environmental liability exposure.
- Legislation and litigation involving pesticides and PFAS.
- Dependence on suppliers and vulnerabilities in global supply chains, including tariff and foreign exchange risks.
- Changes in tax laws, treaties, and other regulatory requirements.
- Considerations related to artificial intelligence and associated risks.
- Macroeconomic conditions, inflation, interest rates, and weather impacts.
- Ability to borrow, service debt, and manage the company’s debt structure.
- Risks from customer prepayments, asset impairments, and previously identified internal control weaknesses.
- Cybersecurity incidents and capacity or supply utilization constraints.
- Availability of capital resources and effects of debt market conditions.
- Competitive pressures, pricing dynamics, and market acceptance of products.
- Development and commercialization risks for new products.
- Risks tied to foreign operations and regulatory policy shifts.
- Risks associated with acquisitions and post-acquisition integration.
